Attached files

file filename
EX-4.8 - DESCRIPTION OF REGISTRANTS SECURITIES - PDL BIOPHARMA, INC.pdli1231201910-kex48.htm
EX-32.1 - CERTIFICATION - PDL BIOPHARMA, INC.pdli1231201910-kex321.htm
EX-31.2 - CERTIFICATION - PDL BIOPHARMA, INC.pdli1231201910-kex312.htm
EX-31.1 - CERTIFICATION - PDL BIOPHARMA, INC.pdli1231201910-kex311.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PDL BIOPHARMA, INC.pdli1231201910-kex231.htm
EX-10.76 - WIND DOWN RETENTION PLAN - PDL BIOPHARMA, INC.pdli1231201910-kex1076.htm
EX-10.75 - FORM OF INDUCEMENT RESTRICTED STOCK AGREEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1075.htm
EX-10.74 - FORM OF NONSTATUTORY INDUCMENT STOCK OPTION AGREEMENT NOTICE SUPPPLEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1074.htm
EX-10.73 - FORM OF NONSTATUTORY INDUCMENT STOCK OPTION AGREEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1073.htm
EX-10.72 - FORM OF STOCK OPTION GRANT NOTICE SUPPLEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1072.htm
EX-10.71 - FORM OF STOCK OPTION AGREEMENT AMENDMENT ACKNOWLEDGEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1071.htm
EX-10.70 - FORM OF STOCK OPTION AGREEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1070.htm
EX-10.69 - FORM OF RESTRICTED STOCK AGREEMENT AMENDMENT ACKNOWLEDGEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1069.htm
EX-10.68 - FORM OF RESTRICTED STOCK AGREEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1068.htm
EX-10.67 - SEVERANCE PLAN - PDL BIOPHARMA, INC.pdli1231201910-kex1067.htm
EX-10.66 - FIFTH AMENDEMENT TO LEASE AGREEMENT - PDL BIOPHARMA, INC.pdli1231201910-kex1066.htm
10-K - 10-K - PDL BIOPHARMA, INC.pdli1231201910-kdoc.htm


Exhibit 21.1

SUBSIDIARIES OF THE REGISTRANT

NAME OF SUBSIDIARY OR ORGANIZATION
 
STATE OF INCORPORATION OR
FORMATION
 
 
 
Depo Sub Manager, LLC
 
Delaware
DFM, LLC
 
Delaware
LENSAR, Inc.
 
Delaware
Noden Pharma DAC
 
Republic of Ireland
Noden Pharma Schweiz GmbH
 
Basel
Noden Pharma USA, Inc.
 
Delaware
PDL Investment Holdings, LLC
 
Delaware